bims-instec Biomed News
on Intestinal stem cells and chemoresistance in colon cancer and intestinal regeneration
Issue of 2026–03–08
thirteen papers selected by
Maria-Virginia Giolito, Université Catholique de Louvain



  1. Cancer Res. 2026 Mar 05.
      Stromal fibroblasts of the mesenchyme regulate critical signaling gradients along the crypt-villus axis in the intestine and provide a niche that supports intestinal stem cells. Here, we reported that PDGFRA-expressing fibroblasts secrete ligands that promote a fetal-like state in the intestinal mucosa during early WNT-mediated tumorigenesis. Data from a mouse model of WNT-driven oncogenesis and single-cell RNA sequencing (RNA-seq) of mesenchyme cell populations revealed a dynamic reprogramming of PDGFRA+ fibroblasts that facilitates WNT-mediated tissue transformation. Functional assays of potential mediators of cell-to-cell communication between these fibroblasts and the oncogenic epithelium revealed that TGFβ signaling is notably induced in PDGFRA+ fibroblasts in the presence of oncogenic epithelium, and TGFβ was essential to sustain fetal-like growth of organoids ex vivo. Reduction of CDX2 in β-catenin mutant intestinal epithelium elevated the fetal-like transcriptome and accelerated WNT-dependent oncogenic transformation in vivo. These results demonstrate that PDGFRA+ fibroblasts are activated during WNT-driven oncogenesis to promote a fetal-like state in the epithelium that precedes and facilitates tumor formation.
    DOI:  https://doi.org/10.1158/0008-5472.CAN-25-0101
  2. Cell Rep. 2026 Mar 04. pii: S2211-1247(26)00123-3. [Epub ahead of print]45(3): 117045
      Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths. Mutations in the tumor-suppressor APC initiate CRC in part by preventing the glycogen synthase kinase 3 (GSK3) kinase from phosphorylating β-CATENIN, leading to its stabilization and transactivation of mitogenic target genes. While the importance of β-CATENIN phosphorylation by GSK3 is well established, APC regulation of GSK3 activity upon other targets is not understood. Here, we identify the H4K20 methyltransferase SETD8 as a target of APC-coordinated GSK3 phosphorylation in the intestinal epithelium. We find that phosphorylation by GSK3 restrains the oncogenic activity of SETD8, with loss of phosphorylation sensitizing mice to oncogenic insults. Mechanistically, loss of SETD8 phosphorylation in tumors results in a loss of H4K20 monomethylation (H4K20me1) deposition at oncogenic cholesterol biosynthesis and fetal intestinal genes, allowing for their activation in part through gain of YAP accessibility. These results underscore the importance of SETD8 in CRC and represent a novel β-CATENIN-independent oncogenic consequence of APC loss.
    Keywords:  APC; CP: cancer; CP: molecular biology; H4K20me1; SETD8; YAP/Hippo; beta catenin; colorectal cancer; fetal reprogramming; intestine; organoid; phosphorylation
    DOI:  https://doi.org/10.1016/j.celrep.2026.117045
  3. NPJ Syst Biol Appl. 2026 Mar 04.
      KRAS-mutant colorectal cancer (CRC) undergoes metabolic reprogramming that promotes tumor progression and drug resistance. Cancer-associated fibroblasts (CAFs), a major component of the tumor microenvironment (TME), play a pivotal role in modulating these metabolic adaptations in CRC. This study applies flux sampling combined with representation learning and hierarchical clustering to a computational model of central carbon metabolism to understand how CAFs influence KRAS-mutant CRC metabolic reprogramming following targeted enzyme knockdowns. Focusing on 12 key enzymes involved in glycolysis and the pentose phosphate pathway, knockdowns were simulated under normal CRC media and CAF-conditioned media (CCM) conditions. Analysis revealed CCM induces greater metabolic heterogeneity, with knockdown models exhibiting more variable and distinct metabolic states compared to those cultured in normal CRC media, indicating CAF-derived factors diversify the metabolic responses of CRC cells to enzyme perturbations. Pathway-level flux analysis demonstrated media-specific shifts in central carbon metabolism. Predicted biomass flux showed enzyme knockdowns reduced growth across both conditions, but CCM models indicated a protective effect against perturbation. Overall, simulations illustrated CCM enhances the metabolic adaptability of KRAS-mutant CRC cells to perturbations, emphasizing the importance of including TME components in metabolic modeling and therapeutic development and suggesting that targeting tumor-CAF metabolic interactions may improve treatment strategies.
    DOI:  https://doi.org/10.1038/s41540-026-00673-8
  4. Biochim Biophys Acta Mol Cell Biol Lipids. 2026 Mar 03. pii: S1388-1981(26)00021-1. [Epub ahead of print] 159735
      The stearoyl-CoA desaturase (SCD) enzymes convert saturated fatty acids to monounsaturated fatty acids (MUFAs). Deletion of intestinal SCD1 confers metabolic benefits upon high-fat diet (HFD) feeding. We report here that mice express a second SCD isoform in the intestine. SCD2 is expressed at much greater levels than SCD1 along the small intestine and colon. SCD2 displays spatial enrichment in the distal small intestine and in the colon and nutritional regulation by dietary fat and sucrose. Deletion of intestinal SCD2 (in 2iKO mice) reduces colonic, hepatic, and plasma triglycerides. However, MUFA levels and desaturation ratios are largely unimpacted in 2iKO intestines. SCD2 deletion is accompanied by upregulation of SCD1 and the fatty acid transporter, CD36, which together may help retain MUFA balance in the gut. Consistent with a lack of impact on MUFA levels, deletion of SCD2 does not protect mice from HFD-induced metabolic dysfunction. However, upon sucrose refeeding, SCD2 deletion blunts hepatic lipogenesis and triglyceride accumulation, suggesting that intestinal SCD2 modulates interorgan communication under conditions of carbohydrate overfeeding. While SCD1 and CD36 likely help retain MUFA balance in 2iKO mice intestines, primary organoids cultured ex vivo indicate significant reductions in overall desaturase activity in 2iKO organoids, despite increases in Scd1 expression. 2iKO organoids do not, however, induce Cd36 expression, and this is accompanied by a significant induction of ER stress in 2iKO organoids. Together, these data reveal a novel role for intestinal SCD2 in maintaining cellular MUFA balance to modulate responses to nutrient overload and to prevent ER stress.
    Keywords:  Colon lipidomics; Gut-liver crosstalk; Intestinal lipid metabolism; Nutrient response; Single-cell RNA-Seq
    DOI:  https://doi.org/10.1016/j.bbalip.2026.159735
  5. Sci Signal. 2026 Mar 03. 19(927): eadz6443
      The JAK-STAT3 signaling pathway is a key driver of colorectal cancer (CRC) progression. STAT3 is a transcription factor that is canonically activated by cytokines, such as IL-6, in a transient manner because of negative feedback mechanisms. However, STAT3 is aberrantly and persistently activated in CRC, promoting tumor cell proliferation and survival. Here, we demonstrated that glucose sustained STAT3 activation independently of cytokine availability. We manipulated glucose metabolism, which showed that both glucose and its downstream metabolite GlcNAc were essential to maintain STAT3 activation. Moreover, cells with high basal STAT3 activity produced proteins that were glycosylated in a glucose-dependent manner and that activated STAT3 in neighboring cells through paracrine signaling. Proteomic analysis identified multiple candidate proteins involved in this process; however, no single protein was sufficient to fully activate STAT3, suggesting that this activation process requires several glycosylated proteins. In a syngeneic mouse model of CRC, inhibition of glycolysis reduced STAT3 activation in tumors, and genetic deletion of STAT3 substantially decreased tumor growth. Together, these findings show how glucose metabolism supports sustained STAT3 activation in CRC, highlighting a potential metabolic vulnerability for therapeutic targeting.
    DOI:  https://doi.org/10.1126/scisignal.adz6443
  6. Cancer Lett. 2026 Feb 28. pii: S0304-3835(26)00121-7. [Epub ahead of print]645 218358
      The metastatic process is largely inefficient, yet its outcome - the dissemination of cancer cells from the primary tumor to distant sites and the formation of metastases - remains the leading cause of cancer-related death. The individual steps of the metastatic cascade impose major challenges and represent bottleneck steps, eliminating the majority of cancer cells along the way. To overcome these barriers, cancer cells must adapt to diverse environments, ranging from confining spaces to fluid, non-adhesive milieus. Distinct invasion strategies, including collective, mesenchymal and amoeboid, confer specific advantages under such conditions. Cancer cells capable of exploiting features of the invasion modes by switching among them are more likely to survive and thrive throughout all steps of the metastatic cascade. Thus, invasion plasticity represents a key adaptive strategy enabling cancer cells to endure metastatic progression. In this review, we concisely summarize the contribution of collective, mesenchymal and amoeboid invasion features during individual steps of the metastatic cascade, highlight evidence that invasion plasticity fuels metastatic dissemination and discuss how targeting such adaptability may reduce metastatic burden.
    Keywords:  Amoeboid; Collective; Invasion; Mesenchymal; Metastatic cascade
    DOI:  https://doi.org/10.1016/j.canlet.2026.218358
  7. Nature. 2026 Mar 04.
      Interactions between mutant cells and their environment have a key role in determining cancer susceptibility1-3. However, understanding of how the precancerous microenvironment contributes to early tumorigenesis remains limited. Here we show that newly emerging tumours at their most incipient stages shape their microenvironment in a critical process that determines their survival. Analysis of nascent squamous tumours in the upper gastrointestinal tract of the mouse reveals that the stress response of early tumour cells instructs the underlying mesenchyme to form a supportive 'precancerous niche', which dictates the long-term outcome of epithelial lesions. Stimulated fibroblasts beneath emerging tumours activate a wound-healing response that triggers a marked remodelling of the underlying extracellular matrix, resulting in the formation of a fibronectin-rich stromal scaffold that promotes tumour growth. Functional heterotypic 3D culture assays and in vivo grafting experiments, combining carcinogen-free healthy epithelium and tumour-derived stroma, demonstrate that the precancerous niche alone is sufficient to confer tumour properties to normal epithelial cells. We propose a model in which both mutations and the stromal response to genetic stress together define the likelihood of early tumours to persist and progress towards more advanced disease stages.
    DOI:  https://doi.org/10.1038/s41586-026-10157-8
  8. Mol Cancer Res. 2026 Mar 03.
      Uncontrolled cellular proliferation is a hallmark of cancer that is both driven by deregulation of the cell cycle, and fueled by metabolic reprogramming. Among the metabolic alterations detected, lipid metabolism is markedly upregulated to provide resources for proliferating cancer cells. Each cell cycle requires lipids for membrane synthesis, energy production, and cellular signaling, yet the mechanistic relationship linking the cell cycle to lipid metabolism in cancer remains incompletely understood. Recent advances in lipidomic technologies that enable comprehensive profiling of the cancer lipidome have provided new insights into the interconnections between these two pathways. This review describes how cell cycle regulators influence various aspects of lipid metabolism in models of cancer and the effect of cell cycle perturbation on cellular lipid profiles. We further describe lipid metabolic changes associated with response and resistance to cell cycle inhibitors in cancer and offer insight into how these findings may inform the development of clinical biomarkers and new therapeutic strategies.
    DOI:  https://doi.org/10.1158/1541-7786.MCR-25-1270
  9. Cancer Discov. 2026 Mar 04.
      Cancer cells that seed in the lung require lipids often produced by alveolar type II (AT2) cells. However, whether overt metastases depend on AT2 cell-derived lipids and whether AT2 cells can be targeted to reduce metastasis growth remains unknown. We discovered that breast cancer-derived lung metastases stimulate the proliferation of AT2 cells in their vicinity and reprogram them into lipid feeder cells in mice and patients using spatial analysis. Mechanistically, the metastasis secretome activates the transcription factor sterol regulatory element-binding transcription factor 1 (SREBP-1) in AT2 cells, enhancing the expression of key de novo lipid synthesis genes including fatty acid synthase (FASN) and glycerol-3-phosphate acyltransferase 1 (GPAM). Deleting Fasn selectively in AT2 cells or targeting FASN and GPAM systemically significantly impairs lung metastasis growth in mice. In summary, we discovered that overt metastases reprogram AT2 cells and that targeting the lipid metabolism of AT2 cells impairs metastasis growth.
    DOI:  https://doi.org/10.1158/2159-8290.CD-25-0191
  10. Am J Pathol. 2026 Feb 26. pii: S0002-9440(26)00055-6. [Epub ahead of print]
      Small intestine adenocarcinomas (SIAC) in humans occur predominantly as extra-ampullary SIAC (SIAC/EDA), demonstrate intestinal-type or gastric-type differentiation and arise from precursor adenomas. The aims of this study were to determine spatial transcriptomics of SIAC/EDA differentiation subtypes and driver molecular pathways in humans and novel mouse models. Spatial transcriptomics and immunohistochemistry were performed in human and murine SIAC/EDA and adenomas. Mice with Cdkn2a/p16 conditional knockout, KrasG12D expression, or both (p16KOKrasG12D) targeting LGR5 cell progenitors were generated, and histologic alterations were examined. Spatial transcriptomics identified differentiation signatures of intestinal and gastric-type SIAC/EDA and adenomas, their microenvironment, cell-cell signaling interactions driving neoplasia progression, and susceptibility to targeted therapies. Activated signaling pathways were not specific to differentiation subtype. Algorithm-inferred susceptibility to MEK inhibitors correlated with activation of MEK pathways in gastric-type SIAC. P16KOKrasG12D mice developed small intestine/duodenal adenomas by 11-15 months (10/14, 83%), and adenocarcinomas by 12-19 months, in contrast to wild-type mice (p=.0003). Spatial transcriptomics of mouse lesions largely replicated human SIAC/EDA differentiation signatures and signaling pathways. A novel genetically engineered mouse model that mimics gastric-type and intestinal-type adenomas and gastric-type SIAC/EDA is reported. Spatial transcriptomics provided a detailed understanding of cellular differentiation lineages, cancer microenvironment related to SIAC subtypes and driving pathways that may be leveraged to identify new molecular tools for pathologic diagnosis and potential targets for precision cancer therapies.
    Keywords:  Small bowel adenocarcinoma; Small intestine adenocarcinoma; extra-ampullary (non-ampullary) duodenal adenocarcinoma; mouse model small intestine cancer; spatial transcriptomics
    DOI:  https://doi.org/10.1016/j.ajpath.2026.01.013